Students in the Indiana University School of Medicine bachelor's degree program in cytotechnology benefit from state-of-the-art laboratory space, simulation centers and the school’s strong clinical affiliations with IU Health, Eskenazi Health and the Richard L. Roudebush VA Medical Center.
This undergraduate degree program is offered at the school’s Indianapolis campus and features faculty educators with extensive experience and passion for studying human cells.
Undergraduate students at Indiana University interested in pursuing a bachelor's degree in cytotechnology are encouraged to apply.
This program prepares competent entry-level cytotechnologists in the cognitive (knowledge), psychomotor (skills) and affective (behavior) learning domains. Program graduates experience Board of Registry Pass Rate of at least 80 percent and job placement rates of at least 75 percent. Specifically, the program has a three-year average (2015-2017) ASCP-Board of Certification first-time pass rate of 100 percent. The student retention rate is at least 80 percent.
Cytotechnology concentrates on the origin of life itself — the cell. Cytotechnologists evaluate cell samples through microscopic analysis to determine any abnormalities. Trained to identify early signs of cancer and infectious diseases, most cytotechnologists work in hospitals or labs and can interact with patients as well as work independently on cell analysis. The job market in this area of medicine is rapidly growing with opportunities and competitive salaries for candidates with the training to detect cancer and infections thorough analysis and molecular diagnostics.
The curriculum of the IU School of Medicine Cytotechnology Program at Indiana University Indianapolis is fully accredited by the Commission on Accreditation of Allied Health Education Programs.
